Clinical Trial Update: Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing SYS6010±SYH2051 versus chemotherapy in advanced breast cancer and other solid tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• SYH2051
• SYS6010

Snippet

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. | Conditions: Advanced Solid Tumors, Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING